Australia markets closed

Seres Therapeutics, Inc. (MCRB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.8485+0.0113 (+1.35%)
At close: 04:00PM EDT
0.8570 +0.01 (+1.00%)
After hours: 07:46PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Sep 2024)Next qtr. (Dec 2024)Current year (2024)Next year (2025)
No. of analysts5656
Avg. Estimate-0.24-0.21-0.97-0.6
Low estimate-0.26-0.27-1.06-0.88
High estimate-0.23-0.12-0.87-0.16
Year ago EPS-0.37-0.32-0.89-0.97
Revenue estimateCurrent qtr. (Sep 2024)Next qtr. (Dec 2024)Current year (2024)Next year (2025)
No. of analysts5656
Avg. EstimateN/AN/AN/A12.25M
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/A73.5M
Year ago sales1.87M64k126.33MN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history29/09/202330/12/202330/03/202429/06/2024
Est. EPS-0.5-0.5-0.34-0.27
Actual EPS-0.37-0.32-0.27-0.22
Difference0.130.180.070.05
Surprise %26.00%36.00%20.60%18.50%
EPS trendCurrent qtr. (Sep 2024)Next qtr. (Dec 2024)Current year (2024)Next year (2025)
Current estimate-0.24-0.21-0.97-0.6
7 days ago-0.24-0.21-0.97-0.6
30 days ago-0.24-0.21-0.97-0.6
60 days ago-0.26-0.24-1.04-0.77
90 days ago-0.26-0.24-1.04-0.77
EPS revisionsCurrent qtr. (Sep 2024)Next qtr. (Dec 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesMCRBIndustrySector(s)S&P 500
Current qtr.35.10%N/AN/AN/A
Next qtr.34.40%N/AN/AN/A
Current year-9.00%N/AN/AN/A
Next year38.10%N/AN/AN/A
Next 5 years (per annum)-134.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A